You just read:

PALM Ebola Clinical Trial Stopped Early as Regeneron's REGN-EB3 Therapy Shows Superiority to ZMapp in Preventing Ebola Deaths

News provided by

Regeneron Pharmaceuticals, Inc.

Aug 12, 2019, 10:01 ET